Tech Company Financing Transactions
Restore Medical Funding Round
On 7/7/2025, Restore Medical secured $23 million in Series B funding from European Innovation Council Fund, Pitango Venture Capital and Peregrine Ventures.
Transaction Overview
Company Name
Announced On
7/7/2025
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series B
Investors
European Innovation Council Fund (Lead Investor)
Pitango Venture Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further enhance the completion of its ongoing European feasibility study, which has demonstrated promising long-term safety and efficacy data, including meaningful improvements in ventricular reverse remodeling, hemodynamic performance, and patient functional capacity.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6 Yoni Netanyahu St., 1st Floor
Or Yehuda, 6037604
Israel
Or Yehuda, 6037604
Israel
Phone
Website
Email Address
Overview
Restore Medical has developed the first and only transcatheter Pulmonary Artery Banding (PAB) system for the treatment of HFrEF patients. Restore Medical is dedicated to improve the treatment of congestive heart failure (CHF) by developing innovative and disruptive medical device that will reduce hospitalizations, mortality, and morbidity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gilad Marom
Browse more venture capital transactions:
Prev: 7/7/2025: Things venture capital transaction
Next: 7/7/2025: Bumo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs